These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 30166241)
21. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies. Piccolo F; Moore SA; Ford GC; Campbell KP Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547 [TBL] [Abstract][Full Text] [Related]
22. Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities. Poudel BH; Fletcher S; Wilton SD; Aung-Htut M Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891760 [TBL] [Abstract][Full Text] [Related]
24. Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy. Demonbreun AR; Fahrenbach JP; Deveaux K; Earley JU; Pytel P; McNally EM Hum Mol Genet; 2011 Feb; 20(4):779-89. PubMed ID: 21127009 [TBL] [Abstract][Full Text] [Related]
25. Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B. Hogarth MW; Defour A; Lazarski C; Gallardo E; Diaz Manera J; Partridge TA; Nagaraju K; Jaiswal JK Nat Commun; 2019 Jun; 10(1):2430. PubMed ID: 31160583 [TBL] [Abstract][Full Text] [Related]
26. Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset. Kesari A; Fukuda M; Knoblach S; Bashir R; Nader GA; Rao D; Nagaraju K; Hoffman EP Am J Pathol; 2008 Nov; 173(5):1476-87. PubMed ID: 18832576 [TBL] [Abstract][Full Text] [Related]
27. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377 [TBL] [Abstract][Full Text] [Related]
28. Dysferlin and animal models for dysferlinopathy. Kobayashi K; Izawa T; Kuwamura M; Yamate J J Toxicol Pathol; 2012 Jun; 25(2):135-47. PubMed ID: 22907980 [TBL] [Abstract][Full Text] [Related]
29. Enhanced Muscular Dystrophy from Loss of Dysferlin Is Accompanied by Impaired Annexin A6 Translocation after Sarcolemmal Disruption. Demonbreun AR; Allen MV; Warner JL; Barefield DY; Krishnan S; Swanson KE; Earley JU; McNally EM Am J Pathol; 2016 Jun; 186(6):1610-22. PubMed ID: 27070822 [TBL] [Abstract][Full Text] [Related]
30. Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin-deficient and mdx mice. White Z; Theret M; Milad N; Tung LW; Chen WW; Sirois MG; Rossi F; Bernatchez P J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):544-560. PubMed ID: 34927367 [TBL] [Abstract][Full Text] [Related]